Education
About Us
Working with TipRanks
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
Total Valuation
AxoGen has a market cap or net worth of $1.68B. The enterprise value is $1.66B.
Market Cap$1.68B
Enterprise Value$1.66B
Share Statistics
AxoGen has 51,897,682 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,897,682
Owned by Insiders1.26%
Owned by Institutions39.02%
Financial Efficiency
AxoGen’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -3.91%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-3.91%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee499.35K
Profits Per Employee-34.82K
Employee Count451
Asset Turnover1.02
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of AxoGen is ―. AxoGen’s PEG ratio is -2.01.
PE Ratio―
PS Ratio6.69
PB Ratio11.70
Price to Fair Value11.70
Price to FCF-513.89
Price to Operating Cash Flow1.87K
PEG Ratio-2.01
Income Statement
In the last 12 months, AxoGen had revenue of 225.21M and earned -15.70M in profits. Earnings per share was -0.34.
Revenue225.21M
Gross Profit167.35M
Operating Income-7.85M
Pretax Income-15.70M
Net Income-15.70M
EBITDA192.00K
Earnings Per Share (EPS)-0.34
Cash Flow
In the last 12 months, operating cash flow was 812.00K and capital expenditures -4.09M, giving a free cash flow of -3.28M billion.
Operating Cash Flow812.00K
Free Cash Flow-3.28M
Free Cash Flow per Share-0.06
Dividends & Yields
AxoGen pays an annual dividend of $1, resulting in a dividend yield of ―
Dividend Per Share$1
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change76.91%
50-Day Moving Average32.64
200-Day Moving Average21.70
Relative Strength Index (RSI)52.25
Average Volume (3m)801.93K
Important Dates
AxoGen upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
AxoGen as a current ratio of 5.11, with Debt / Equity ratio of 14.93%
Current Ratio5.11
Quick Ratio3.31
Debt to Market Cap0.01
Net Debt to EBITDA-84.93
Interest Coverage Ratio-1.02
Taxes
In the past 12 months, AxoGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AxoGen EV to EBITDA ratio is 7.77K, with an EV/FCF ratio of -508.33.
EV to Sales6.62
EV to EBITDA7.77K
EV to Free Cash Flow-508.33
EV to Operating Cash Flow1.84K
Balance Sheet
AxoGen has $35.55M in cash and marketable securities with $19.24M in debt, giving a net cash position of $16.31M billion.
Cash & Marketable Securities$35.55M
Total Debt$19.24M
Net Cash$16.31M
Net Cash Per Share$0.31
Tangible Book Value Per Share$2.65
Margins
Gross margin is 74.31%, with operating margin of -3.49%, and net profit margin of -6.97%.
Gross Margin74.31%
Operating Margin-3.49%
Pretax Margin-6.97%
Net Profit Margin-6.97%
EBITDA Margin0.09%
EBIT Margin-3.55%
Analyst Forecast
The average price target for AxoGen is $40.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$40.29
Price Target Upside24.58% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast18.72%
EPS Growth Forecast85.77%